Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
and other factors described in the Risk Factors and other sections of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other current and periodic reports we file from time to time with the Securities and Exchange Commission
Managing Energy Levels and Preventing Low Blood Sugar Maintaining stable energy levels whilst taking GLP-1 medications and exercising regularly requires vigilance, particularly for individuals with diabetes who face additional considerations regarding blood glucose management
Another benefit was that 20 percent of patients with type 2 diabetes who took liraglutide were able to reduce or discontinue their treatment with insulin (Holst 2024)
GLP-1 medications such as semaglutide and tirzepatide are injected under the skin (subcutaneous), not into muscle
